Bolt Biotherapeutics (BOLT) Operating Leases (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Operating Leases of $19.4 million for Q1 2026, down 3.87% sequentially from $20.1 million in Q4 2025, and down 13.25% YoY from $22.3 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Operating Leases (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Operating Leases for 7 years, with the latest figure at $19.4 million in Q1 2026.
- Quarterly Operating Leases fell 13.25% year-over-year to $19.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.4 million (down 13.25% YoY) and the FY2025 annual result came in at $20.1 million, down 12.31% from the prior year.
- Operating Leases slipped to $19.4 million in Q1 2026 per BOLT's latest filing, from $20.1 million in the prior quarter.
- Over five years, Operating Leases peaked at $23.0 million in Q4 2024 and troughed at $15.4 million in Q3 2024.
- A 5-year average of $19.6 million and a median of $20.1 million in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2024: Operating Leases jumped 135.34% in 2022, then fell 15.85% in 2024.
- Over 5 years, Operating Leases stood at $20.2 million in 2022, then dropped by 13.76% to $17.4 million in 2023, then surged by 31.66% to $23.0 million in 2024, then declined by 12.31% to $20.1 million in 2025, then declined by 3.87% to $19.4 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $19.4 million, $20.1 million, and $20.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bolt Biotherapeutics | 6.10 Mn | 6.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.53 Mn |
| Mar 31, 2026 | 19.35 Mn |
| Dec 31, 2025 | 20.13 Mn |
| Sep 30, 2025 | 20.89 Mn |
| Jun 30, 2025 | 21.62 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Dec 31, 2024 | 22.96 Mn |
| Sep 30, 2024 | 15.35 Mn |
| Jun 30, 2024 | 15.90 Mn |
| Mar 31, 2024 | 16.68 Mn |
| Dec 31, 2023 | 17.44 Mn |
| Sep 30, 2023 | 18.18 Mn |
| Jun 30, 2023 | 18.89 Mn |
| Mar 31, 2023 | 19.57 Mn |
| Dec 31, 2022 | 20.22 Mn |
| Sep 30, 2022 | 20.86 Mn |
| Jun 30, 2022 | 20.75 Mn |
| Mar 31, 2022 | 21.31 Mn |
| Dec 31, 2021 | 21.85 Mn |
| Sep 30, 2021 | 22.52 Mn |